Alternatives to Tharimmune
Tharimmune is a Biotech tool: biotechnology company developing novel immunotherapies for cancer. Here are the 49 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Tharimmune
Bristol Myers SquibbNot ratedA global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.
Gilead SciencesNot ratedBiopharmaceutical company focused on developing and commercializing innovative medicines.
ImmunoScapeNot ratedDeveloping novel immunotherapies and diagnostics for cancer.
- Aptevo Therapeutics Inc.Not rated
A clinical-stage biotechnology company developing novel bispecific and trispecific immunotherapies for the treatment of cancer.
ImmunityBioNot ratedA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Ella TherapeuticsNot ratedDeveloping microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
Umlaut.bioNot ratedDeveloping novel immunotherapies for cancer.
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
Cue Biopharma, .Not ratedDeveloping engineered biologics to harness the immune system for disease treatment.
Caris Life SciencesNot ratedCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Guardant HealthNot ratedGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
MacroGenicsNot ratedBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
C4 TherapeuticsNot ratedBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
Adicet Bio3.0 out of 5 (1)Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
32 Biosciences1.0 out of 5 (1)Develops novel therapeutic antibodies for oncology and autoimmune diseases.
Intellia TherapeuticsNot ratedA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Sutro BiopharmaNot ratedClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
CureVacNot ratedBiopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.
Ferring PharmaceuticalsNot ratedA global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.
MabylonNot ratedMabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.
Showing the next 20 closest matches. See the rest on the Tharimmune profile.
Sponsored rows are paid and labelled. Advertise on this page

